TickerFacts.

TriSalus Life Sciences, Inc. (TLSI): Revenue

Annual figures by period end, from SEC filings.

$45.15M
Year ended 2025-12-31
$45.08M
Trailing 12 months to 2026-06-30
+53.9%
3-year compound annual growth
2022-12-31: $12.40M2023-12-31: $18.51M2024-12-31: $29.43M2025-12-31: $45.15M$45.15M
2022-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$45.15M+53.4%2026-03-05, From 2025-01-01
2024-12-31$29.43M+59.0%2026-03-05, From 2024-01-01
2023-12-31$18.51M+49.3%2025-05-30, From 2023-01-01
2022-12-31$12.40Mn/a2024-04-11, From 2022-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
TriSalus Life Sciences, Inc. (TLSI)2025-12-31$45.15M+53.4%
SANUWAVE Health, Inc. (SNWV)2025-12-31$44.05M+35.0%
Shoulder Innovations, Inc. (SI)2025-12-31$47.32M+49.6%
SS Innovations International, Inc. (SSII)2025-12-31$42.48M+105.7%
KORU Medical Systems, Inc. (KRMD)2025-12-31$41.13M+22.2%
Carlsmed, Inc. (CARL)2025-12-31$50.51M+85.9%
Interpace Biosciences, Inc. (IDXG)2025-12-31$38.73M-17.5%
Apyx Medical Corp (APYX)2025-12-31$52.84M+9.9%
Utah Medical Products Inc (UTMD)2025-12-31$38.52M-5.8%

Compare TLSI, SNWV, SI, SSII side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗